Study summary

The purpose of this study was to evaluate the efficacy and safety of enzalutamide plus androgen deprivation therapy (ADT) versus placebo plus ADT in Chinese subjects with metastatic hormone sensitive prostate cancer (mHSPC). The study was conducted in two phases: Double-Blind treatment phase and open-label phase.

Additional Study Details

Phase
Phase 3
Product
  • Enzalutamide
  • Placebo
  • Androgen deprivation therapy (ADT)
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    180
    Show Additional Study Details

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Active, not recruiting
      Site CN86003
      Shanghai, China
      Active, not recruiting
      Site CN86026
      Wuhan, China
      Active, not recruiting
      Site CN86013
      Shanghai, China
      Active, not recruiting
      Site CN86004
      Nanchang, China
      Active, not recruiting
      Site CN86025
      Fuzhou, China
      Active, not recruiting
      Site CN86020
      Shenyang, China
      Completed
      Site CN86035
      Beijing, China
      Active, not recruiting
      Site CN86011
      Shenzhen, China
      Withdrawn
      Site CN86030
      Qingdao, China
      Active, not recruiting
      Site CN86001
      Guangzhou, China
      Active, not recruiting
      Site CN86016
      Changsha, China
      Active, not recruiting
      Site CN86014
      Shanghai, China
      Active, not recruiting
      Site CN86029
      Zhengzhou, China
      Active, not recruiting
      Site CN86032
      Suzhou, China
      Active, not recruiting
      Site CN86005
      Wulumuqi, China
      Active, not recruiting
      Site CN86017
      Zhengzhou, China
      Active, not recruiting
      Site CN86028
      Hangzhou, China
      Active, not recruiting
      Site CN86012
      Tianjin, China
      Active, not recruiting
      Site CN86036
      Hangzhou, China
      Active, not recruiting
      Site CN86023
      Changsha, China
      Active, not recruiting
      Site CN86019
      Wuhan, China
      Active, not recruiting
      Site CN86022
      Beijing, China
      Completed
      Site CN86010
      Shanghai, China
      Completed
      Site CN86027
      Shanghai, China
      Active, not recruiting
      Site CN86021
      Wuxi, China
      Active, not recruiting
      Site CN86009
      Changsha, China
      Active, not recruiting
      Site CN86002
      Shanghai, China
      Active, not recruiting
      Site CN86038
      Xi'an, China
      Withdrawn
      Site CN86031
      Shenzhen, China
      Completed
      Site CN86024
      Changchun, China

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?